INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP)

CUSIP: 46137V662

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / PHARMACEUTICALS
Total 13F shares
759,068
Share change
-16,844
Total reported value
$65,987,834
Price per share
$86.97
Number of holders
97
Value change
-$1,444,326
Number of buys
31
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 46137V662?
CUSIP 46137V662 identifies PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2024

As of 30 Sep 2024, INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 759,068 shares. The largest 10 holders included Peak Asset Management, LLC, MORGAN STANLEY, LPL Financial LLC, BANK OF AMERICA CORP /DE/, Cambridge Investment Research Advisors, Inc., UBS Group AG, Federation des caisses Desjardins du Quebec, WELLS FARGO & COMPANY/MN, ENVESTNET ASSET MANAGEMENT INC, and MGB Wealth Management, LLC. This page lists 97 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.